Literature DB >> 11156729

Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.

K R Campbell1, K W Mahaffey, B E Lewis, J I Weitz, S D Berkowitz, E M Ohman, R M Califf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11156729

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN： 1042-3931            Impact factor:   2.022


× No keyword cloud information.
  10 in total

Review 1.  Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes.

Authors:  E R Bates
Journal:  Curr Cardiol Rep       Date:  2001-09       Impact factor: 2.931

Review 2.  Novel oral anticoagulants for heparin-induced thrombocytopenia.

Authors:  Jessica W Skelley; Jeffrey A Kyle; Rachel A Roberts
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

Review 3.  Anticoagulation for acute coronary syndromes and percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.

Authors:  K W Mahaffey
Journal:  Curr Cardiol Rep       Date:  2001-09       Impact factor: 2.931

4.  Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee.

Authors:  E Magnus Ohman; Christopher B Granger; Lawrence Rice; Charles S Abrams; Richard C Becker; Peter B Berger; Neal S Kleiman; David Moliterno; Stephan Moll; Jo E Rodgers; Stephen S Steinhubl; Victor F Tapson; Peter Sinnaeve; Kevin J Anstrom
Journal:  J Thromb Thrombolysis       Date:  2005-02       Impact factor: 2.300

Review 5.  Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.

Authors:  E Marc Jolicoeur; Tracy Wang; Renato D Lopes; E Magnus Ohman
Journal:  Curr Cardiol Rep       Date:  2007-09       Impact factor: 2.931

Review 6.  Heparin induced thrombocytopenia: diagnosis and management update.

Authors:  I Ahmed; A Majeed; R Powell
Journal:  Postgrad Med J       Date:  2007-09       Impact factor: 2.401

7.  Evaluation of a rapid and automated heparin-induced thrombocytopenia immunoassay.

Authors:  Majed A Refaai; Grace Conley; Thomas L Ortel; John L Francis
Journal:  Int J Lab Hematol       Date:  2019-04-15       Impact factor: 2.877

Review 8.  Elucidation of Cellular Contributions to Heparin-Induced Thrombocytopenia Using Omic Approaches.

Authors:  Jason B Giles; Elise C Miller; Heidi E Steiner; Jason H Karnes
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

9.  Severe heparin-induced thrombocytopenia: when the obvious is not obvious, a case report.

Authors:  Graham M Cormack; Larry J Kaufman
Journal:  J Med Case Rep       Date:  2007-04-30

Review 10.  Risks and complications of coronary angiography: a comprehensive review.

Authors:  Morteza Tavakol; Salman Ashraf; Sorin J Brener
Journal:  Glob J Health Sci       Date:  2012-01-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.